Implementing Cancer Rehabilitation to Improve Quality of Life

Commentary
Video

Jessica Cheng, MD, noted that working with patients in the field of cancer rehabilitation to improve recovery times brings her joy.

As a newer field of study, cancer rehabilitation may not be easily discernable as to what type of care is provided. However, Jessica Cheng, MD, is determined to shed light on this new specialty and how it can help improve cancer outcomes.

Cheng, assistant clinical professor in the Department of Supportive Care Medicine at City of Hope, focuses on 3 aspects: before, during, and after treatment. The field of cancer rehabilitation was created to help patients improve their quality of life no matter what stage they are in.

Through creating exercise plans and helping with pain derived from various therapies, Cheng and her team are dedicated to helping patients get back to living the life they knew prior to a cancer diagnosis.

Transcript:

A lot of times when [patients have] cancer, they have thoughts like, “Will I be able to go back to work? Can I go to my son’s wedding? Can I keep golfing? My back hurts; it’s hard to get off a chair. How am I going to get through this?” What I do in my practice in cancer rehabilitation medicine is I then ask a lot more questions about where these thoughts are coming from. I do an extensive physical exam, and I come up with a comprehensive, tailored, practical, and coordinated plan that aims to give the patient a measure of control over their life, to live their life to the fullest no matter where they are in their cancer journey.

A key part of that in being able to function and do the activities that they want to do is exercise. There can be a lot of barriers to exercise. It could be that back pain, it could be fatigue related to cancer, neuropathy, or [something that makes them say] “Why do I have to do that?” I seek to answer all those questions with my patients. That’s one example of what a visit might look like. The part that I’m passionate about is cancer prehabilitation, and that’s preparing for surgery, stem cell transplant, or whichever cancer treatment is coming up next. I had a patient who recently followed up with me after prehabilitation, and she followed everything I said in terms of exercise, nutrition, mental health, etc. [She said she] got out of the hospital faster, and she recovered much faster than she thought. The oncologist confirmed that was a quicker recovery than expected. That brings me joy.

Recent Videos
Success with the 177Lu-PSMA-617 radioligand therapy would be transformative for the clear cell renal cell carcinoma treatment landscape.
An ongoing phase 1 trial seeks to prove XmAb819 as an effective treatment and ENPP3 as a plausible target in patients with relapsed or refractory RCC.
“The therapy is designed to prevent both CAR T-cell inactivation and to restore the anti-tumor immunity of the white blood cells that have gotten through the tumor,” said Marasco, MD, PhD.
Ongoing studies aim to combine base immunotherapy regimens with novel agents to potentially improve outcomes among patients with kidney cancer.
Investigators have found a way to reduce liver and biliary toxicity when targeting the molecule CAIX in patients with clear cell renal cell carcinoma.
Neoantigen-targeting vaccines resulted in an absence of recurrence in 9 patients with high-risk kidney cancer, according to David A. Braun, MD, PhD.
The Kidney Cancer Research Consortium may allow collaborators to form more mechanistic and scientifically driven efforts in the field.
Wayne A. Marasco, MD, PhD, stated that by targeting 2 molecules instead of 1, higher levels of tumor cell killing can be achieved in patients with clear cell renal cell carcinoma.
Leading experts in the breast cancer field highlight the use of CDK4/6 inhibitors, antibody-drug conjugates, and other treatment modalities.
Related Content